Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 1,979.00
+22.00 (1.12%)
Last updated: Oct 2, 2025, 9:00 AM KST
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 361.94 billion as of October 6, 2025. Its market cap has decreased by -15.61% in one year.
Market Cap
361.94B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
37.00
Stock Price
1,979.00
Market Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 361.94B, an increase of 485.64%. That is a compound annual growth rate of 5.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 361.94B | -0.45% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | 1,470.46B | 21.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |